Insider Transactions Reported by 20 Insiders of Lexeo Therapeutics, Inc.

Symbol
LXEO on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Lexeo Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Longitude Capital Partners IV, LLC 10%+ Owner $33,933,468 07 Nov 2023
Omega Fund VI, L.P. 10%+ Owner $28,520,755 07 Nov 2023
Lundbeckfond Invest A/S 10%+ Owner $24,268,808 07 Nov 2023
Richard Nolan Townsend Chief Executive Officer, Director $2,504,826 -$200,991 -7.4% 18 Feb 2026
Louis Edward Tamayo Chief Financial Officer $890,373 04 Feb 2026
Jose Manuel Otero Chief Operating Officer $802,592 -$58,185 -6.8% 18 Feb 2026
Eric Adler Chief Medical Officer $673,428 -$40,404 -5.7% 18 Nov 2025
Jenny Robertson Chief Legal Officer $633,891 -$40,594 -6% 18 Nov 2025
Tai Sandi See Chief Development Officer $606,962 -$41,146 -6.3% 18 Nov 2025
Narinder Pal Bhalla Chief Medical Officer $367,785 13 Feb 2026
Kyle Rasbach Chief Financial Officer $335,032 17 Jan 2025
Paul McCormac Chief Technical Officer $229,329 07 Nov 2023
PAULA H. CHOLMONDELEY Director $214,086 26 Jun 2025
Bernard Davitian Director 02 Nov 2023
Tolga Tanguler Director 26 Jun 2025
REINALDO M. DIAZ Director 26 Jun 2025
BRENDA COOPERSTONE Director 26 Jun 2025
Steven Altschuler Director 26 Jun 2025
Timothy Van Hauwermeiren Director 26 Jun 2025
Mette Kirstine Agger Director 26 Jun 2025

Recent Insider Transactions by Companies or Individuals for Lexeo Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.